Liang, F., Zhang, S., Wang, Q., & Li, W. (2020). Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration. BMC Cancer.
Chicago ZitierstilLiang, Fei, Sheng Zhang, Qin Wang, und Wenfeng Li. "Clinical Benefit of Immune Checkpoint Inhibitors Approved By US Food and Drug Administration." BMC Cancer 2020.
MLA ZitierstilLiang, Fei, Sheng Zhang, Qin Wang, und Wenfeng Li. "Clinical Benefit of Immune Checkpoint Inhibitors Approved By US Food and Drug Administration." BMC Cancer 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.